Senthil et al. 32 reported that plasma from ovarian cancer patients shows decreased anti-oxidant enzyme activities including catalase, extracellular SOD, and non-enzymatic antioxidants such as vitamin C and E along with increased concentrations of plasma thiobarbituric acid reactive substances and conjugated dienes. This evidence concerns the gene SOD1 and ovarian cancer.